Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.

Journal of autoimmunity - 1 Jun 2024

Chevalier Kevin, Chassagnon Guillaume, Leonard-Louis Sarah, Cohen Pascal, Dunogue Bertrand, Regent Alexis, Thoreau Benjamin, Mouthon Luc, Chaigne Benjamin

Abstract excerpt

OBJECTIVES: To clarify the impact of anti-U1RNP antibodies on the clinical features and prognosis of patients with SSc. METHODS: We conducted a monocentric case-control, retrospective, longitudinal study. For each patient with SSc and anti-U1RNP antibodies (SSc-RNP+), one patient with mixed connective tissue disease (MCTD) and 2 SSc patients without anti-U1RNP antibodies (SSc-RNP-) were matched for age, sex, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Longitudinal Studies

Share to Prognosis

Share to Ribonucleoprotein, U1 Small Nuclear

Share to Scleroderma, Systemic

Share to Sjogren's Syndrome

Source

Identifiers

PMID: 38642508
DOI: 10.1016/j.jaut.2024.103220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.PMID 38642508Read ↗

Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.Semantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcomeSemantic proximity Read ↗

The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.Semantic proximity Read ↗

Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.Semantic proximity Read ↗

Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.Semantic proximity Read ↗

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associationsSemantic proximity Read ↗

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosisSemantic proximity Read ↗

Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype.Semantic proximity Read ↗

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.Semantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

LONG-TERM FOLLOW-UP OF 46 PATIENTS WITH ANTI-(U1)snRNP ANTIBODIESSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.